88064146 - M

Information

  • Trademark
  • 88064146
  • Serial Number
    88064146
  • Registration Number
    6367149
  • Filing Date
    August 03, 2018
    6 years ago
  • Registration Date
    June 01, 2021
    3 years ago
  • Transaction Date
    May 04, 2023
    a year ago
  • Status Date
    June 01, 2021
    3 years ago
  • Published for Opposition Date
    March 16, 2021
    3 years ago
  • Location Date
    June 01, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MESSICK, TABITHA LEE
  • Attorney Docket Number
    SWA0477TUS
    Attorney Name
    Michelle P. Ciotola
    Law Office Assigned Location Code
    L40
  • Owners
Mark Drawing Code
5000
Mark Identification
M
Case File Statements
  • GS0401: Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies
  • DM0000: The mark consists of a stylized letter "M". The two outside legs of the "M" are in blue and gradually fade to turquoise and green in the center of the "M". The color white is background of the mark and is not claimed as a feature of the mark.
  • GS0051: Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
  • CC0000: The color(s) blue, turquoise, and green is/are claimed as a feature of the mark.
  • GS0351: Wholesale store, retail store, and online retail store services featuring pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies
  • GS0421: Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Case File Event Statements
  • 5/4/2023 - a year ago
    40 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 5/4/2023 - a year ago
    39 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/4/2023 - a year ago
    38 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 5/4/2023 - a year ago
    37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/4/2023 - a year ago
    36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/4/2023 - a year ago
    35 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/1/2021 - 3 years ago
    34 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/16/2021 - 3 years ago
    33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/16/2021 - 3 years ago
    32 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/24/2021 - 3 years ago
    31 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/5/2021 - 3 years ago
    30 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/2/2021 - 3 years ago
    29 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/2/2021 - 3 years ago
    28 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/2/2021 - 3 years ago
    27 - ASSIGNED TO LIE Type: ALIE
  • 1/22/2021 - 3 years ago
    26 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 8/21/2020 - 4 years ago
    25 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 8/21/2020 - 4 years ago
    24 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 8/21/2020 - 4 years ago
    23 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 2/21/2020 - 4 years ago
    22 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 2/21/2020 - 4 years ago
    21 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 2/21/2020 - 4 years ago
    20 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 2/18/2020 - 4 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/18/2020 - 4 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/14/2020 - 4 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 2/11/2020 - 4 years ago
    16 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 9/5/2019 - 5 years ago
    15 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 9/5/2019 - 5 years ago
    14 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 9/5/2019 - 5 years ago
    13 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 3/5/2019 - 5 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 3/5/2019 - 5 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 3/5/2019 - 5 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 2/26/2019 - 5 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/25/2019 - 5 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/25/2019 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/1/2018 - 6 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/1/2018 - 6 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/1/2018 - 6 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/30/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/9/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/7/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP